טוען...
Advancing Trial Design in Progressive Multiple Sclerosis
The failure of a majority of clinical trials in progressive MS has highlighted the need to reconsider how these trials are designed and conducted, and many areas deserve focus. Basic scientists are reconceptualising the pathophysiology of progressive MS into three broad areas: systemic inflammation,...
שמור ב:
| הוצא לאור ב: | Mult Scler |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5714314/ https://ncbi.nlm.nih.gov/pubmed/29041871 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458517729768 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|